BR112016001400A2 - uso de ácidos fenoxialquilcarboxílicos para preparação de medicamentos para a redução de níveis sanguíneos de triglicerídeos, colesterol total e lipoproteínas de baixa densidade - Google Patents

uso de ácidos fenoxialquilcarboxílicos para preparação de medicamentos para a redução de níveis sanguíneos de triglicerídeos, colesterol total e lipoproteínas de baixa densidade

Info

Publication number
BR112016001400A2
BR112016001400A2 BR112016001400A BR112016001400A BR112016001400A2 BR 112016001400 A2 BR112016001400 A2 BR 112016001400A2 BR 112016001400 A BR112016001400 A BR 112016001400A BR 112016001400 A BR112016001400 A BR 112016001400A BR 112016001400 A2 BR112016001400 A2 BR 112016001400A2
Authority
BR
Brazil
Prior art keywords
triglycerides
low
total cholesterol
blood levels
reduce blood
Prior art date
Application number
BR112016001400A
Other languages
English (en)
Other versions
BR112016001400B1 (pt
BR112016001400A8 (pt
Inventor
Kazuko Matsuda
Original Assignee
Medicinova Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Medicinova Inc filed Critical Medicinova Inc
Publication of BR112016001400A2 publication Critical patent/BR112016001400A2/pt
Publication of BR112016001400A8 publication Critical patent/BR112016001400A8/pt
Publication of BR112016001400B1 publication Critical patent/BR112016001400B1/pt

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/185Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19Carboxylic acids, e.g. valproic acid
    • A61K31/192Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid 
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/06Antihyperlipidemics
BR112016001400-6A 2013-07-25 2014-07-23 Uso de ácidos fenoxialquilcarboxílicos para preparação de medicamentos para a redução de níveis sanguíneos de triglicerídeos, colesterol total e lipoproteínas de baixa densidade BR112016001400B1 (pt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201361858450P 2013-07-25 2013-07-25
US61/858,450 2013-07-25
PCT/US2014/047797 WO2015013395A1 (en) 2013-07-25 2014-07-23 Methods for reducing triglyceride, total cholesterol and low density lipoprotein blood levels

Publications (3)

Publication Number Publication Date
BR112016001400A2 true BR112016001400A2 (pt) 2017-07-25
BR112016001400A8 BR112016001400A8 (pt) 2020-01-14
BR112016001400B1 BR112016001400B1 (pt) 2023-02-28

Family

ID=52391020

Family Applications (1)

Application Number Title Priority Date Filing Date
BR112016001400-6A BR112016001400B1 (pt) 2013-07-25 2014-07-23 Uso de ácidos fenoxialquilcarboxílicos para preparação de medicamentos para a redução de níveis sanguíneos de triglicerídeos, colesterol total e lipoproteínas de baixa densidade

Country Status (9)

Country Link
US (2) US20150031769A1 (pt)
EP (1) EP3024454B1 (pt)
JP (1) JP6363192B2 (pt)
KR (1) KR102352728B1 (pt)
CN (1) CN105407884B (pt)
BR (1) BR112016001400B1 (pt)
CA (1) CA2917780C (pt)
ES (1) ES2843511T3 (pt)
WO (1) WO2015013395A1 (pt)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA3217719A1 (en) * 2021-05-28 2022-12-01 Kazuko Matsuda Phenoxyalkylcarboxylic acid derivatives and their use in lowering triglyceride levels

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2585246A1 (fr) 1985-07-26 1987-01-30 Cortial Procede d'obtention de formes pharmaceutiques solides a liberation prolongee
US4788055A (en) 1985-12-09 1988-11-29 Ciba-Geigy Corporation Resinate sustained release dextromethorphan composition
GB8613688D0 (en) 1986-06-05 1986-07-09 Euro Celtique Sa Pharmaceutical composition
GB8613689D0 (en) 1986-06-05 1986-07-09 Euro Celtique Sa Pharmaceutical composition
US4816264A (en) 1986-06-06 1989-03-28 Warner-Lambert Company Sustained release formulations
US4985585A (en) 1988-03-07 1991-01-15 Kyorin Pharmaceutical Co., Ltd. Phenoxyalkylcarboxylic acid derivatives and process for their preparations
US4996047A (en) 1988-11-02 1991-02-26 Richardson-Vicks, Inc. Sustained release drug-resin complexes
CA2002492A1 (en) 1988-11-11 1990-05-11 Sandra T. A. Malkowska Pharmaceutical ion exchange resin composition
US5133974A (en) 1989-05-05 1992-07-28 Kv Pharmaceutical Company Extended release pharmaceutical formulations
US5290812A (en) 1991-01-18 1994-03-01 Kyorin Pharmaceutical Co., Ltd. Phenoxyalkylcarboxylic acid derivatives and process of preparing the same
US7064146B2 (en) 2003-06-24 2006-06-20 Medicinova, Inc. Pharmaceutical compositions of isolated orthorhombic crystalline 4-[6-acetyl-3-[3-(4-acetyl-3-hydroxy-2-propylphenylthio)propoxy]-2-propylphenoxy]butyric acid and methods of use
US7060854B2 (en) 2003-06-24 2006-06-13 Medicinova, Inc. Process for making polymorphic form A of 4-[6-acetyl-3-[3-(4-acetyl-3-hydroxy-2-propylphenylthio)propoxy]-2-propylphenoxy]butyric acid
WO2005105073A1 (en) * 2004-04-27 2005-11-10 Medicinova, Inc. Phenoxyalkycarboxylic acid derivatives in the treatment of inflammatory diseases
MX2007000142A (es) * 2004-06-30 2007-03-26 Combinatorx Inc Metodos y reactivos para el tratamiento de desordenes metabolicos.
EP1894576B1 (en) * 2005-06-08 2011-05-25 Kowa Company, Ltd. Novel triglyceride reducing agent
WO2009002746A1 (en) * 2007-06-22 2008-12-31 Decode Genetics Ehf. Dosing schedules of leukotriene synthesis inhibitors for human therapy

Also Published As

Publication number Publication date
US20150031769A1 (en) 2015-01-29
JP6363192B2 (ja) 2018-07-25
JP2016525546A (ja) 2016-08-25
BR112016001400B1 (pt) 2023-02-28
US20150080471A1 (en) 2015-03-19
EP3024454A1 (en) 2016-06-01
CA2917780A1 (en) 2015-01-29
EP3024454A4 (en) 2017-03-15
CN105407884B (zh) 2019-04-30
ES2843511T3 (es) 2021-07-19
KR102352728B1 (ko) 2022-01-18
BR112016001400A8 (pt) 2020-01-14
WO2015013395A1 (en) 2015-01-29
EP3024454B1 (en) 2020-10-21
CN105407884A (zh) 2016-03-16
KR20160034324A (ko) 2016-03-29
US9358217B2 (en) 2016-06-07
CA2917780C (en) 2023-01-24

Similar Documents

Publication Publication Date Title
CR20150380A (es) Compuestos de carbamoilpiridona policíclicos y su uso farmacéutico
BR112015015758A2 (pt) dispersão sólida, formulação sólida, método de preparo de uma dispersão sólida, preparação farmacêutica e uso de uma dispersão sólida
BR302013006823S1 (pt) Configuração aplicada em curativo médico
BR112015001899A2 (pt) interface de paciente e método para produzir a mesma.
BR112013018877A2 (pt) composições farmacêuticas que compreendem anticorpos humanos para pcsk9
CL2014003232A1 (es) Formulaciones y métodos para la administración vaginal de antiprogestinas.
BR112013020362A2 (pt) processos para a preparação de compostos de quinolina, compostos e combinações farmacêuticas que os contem
ES1078818Y (es) Cápsula para preparar infusiones
BR302013006430S1 (pt) Configuração aplicada em cama para paciente
BR112015002681A2 (pt) método para tratar um paciente e kit
BR112015029267A2 (pt) processos para a preparação de desidroepiandrosterona e seus intermediários
BR112014026553A2 (pt) Fralda descartável
DK3079655T3 (da) Inhalerbare lægemidler
BR112014026557A2 (pt) fralda descartável.
CO7010828A2 (es) Preparación farmacéutica que comprende ߖciclodextrina sustituida
CL2016001369A1 (es) Procedimiento para la preparación de un emulsionado de aceite en agua
CO6920303A2 (es) Preparación plaguicida y procedimiento para su preparación
DK3473255T3 (da) Farmaceutisk formulering omfattende ciclesonid
DK3003401T3 (da) Farmaceutisk præparat
BR112014010432A2 (pt) uso médico
CL2016001062A1 (es) Composiciones y métodos para administración de una enzima a las vías respiratorias de un sujeto
DK3046537T3 (da) Farmaceutisk fremstilling af kulhydrater til terapeutisk anvendelse
BR112016001400A2 (pt) uso de ácidos fenoxialquilcarboxílicos para preparação de medicamentos para a redução de níveis sanguíneos de triglicerídeos, colesterol total e lipoproteínas de baixa densidade
DK3076990T3 (da) Biologisk aktive insulinderivater
BR112015033065A8 (pt) nanopartícula de lipídio; composição farmacêutica; e uso da nanopartícula de lipídio

Legal Events

Date Code Title Description
B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]
B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B07E Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette]

Free format text: NOTIFICACAO DE ANUENCIA RELACIONADA COM O ART 229 DA LPI

B06U Preliminary requirement: requests with searches performed by other patent offices: procedure suspended [chapter 6.21 patent gazette]
B350 Update of information on the portal [chapter 15.35 patent gazette]
B06A Patent application procedure suspended [chapter 6.1 patent gazette]
B25G Requested change of headquarter approved

Owner name: MEDICINOVA, INC. (US)

B09A Decision: intention to grant [chapter 9.1 patent gazette]
B16A Patent or certificate of addition of invention granted [chapter 16.1 patent gazette]

Free format text: PRAZO DE VALIDADE: 20 (VINTE) ANOS CONTADOS A PARTIR DE 23/07/2014, OBSERVADAS AS CONDICOES LEGAIS